ONC vs ORKA Stock Comparison
ONC currently leads ORKA in this stock comparison, with AIQ scores of 80 vs 77. The clearest difference is risk resilience, while ORKA has the stronger quality profile.
What is the main difference between ONC and ORKA?
ONC leads the current stock comparison as BeOne Medicines AG, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
BeOne Medicines AG vs Oruka Therapeutics, Inc.
ONC leads
ONC leads by 3 AIQ points, primarily on Risk Resilience and Momentum, but the lead has narrowed from 8 points over 30 sessions. Wall Street currently favors ORKA on target upside.
Fragile: 1 of 5 evidence groups support ONC, its lead is narrowing, and its current signal state is conflicted.
BeOne Medicines AG
Oruka Therapeutics, Inc.
The Algovestiq AIQ Score currently favors ONC over ORKA, 80 versus 77 as of Nov 15, 2026. ONC's advantage is driven primarily by stronger risk resilience and momentum, while ORKA holds the stronger quality profile. ONC also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors ORKA. 1 of 5 covered evidence groups favor ONC today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. ONC lead: Weakening — the AIQ differential moved from 8 to 3 points over 30 sessions.
Compare BeOne Medicines AG and Oruka Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare ONC and ORKA against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience72 vs 53ONC +19
- Momentum91 vs 81ONC +10
- Quality78 vs 83ORKA +5
1 of 5 evidence groups favor ONC. ONC’s edge is concentrated in risk resilience and momentum; ORKA keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 7 active signals are unchanged.
Largest factor move: Momentum +2
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
ONC's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — ONC and ORKA both carry a full feed there.
The central trade-off
ONC (BeOne Medicines AG): the stronger current systematic profile, led by risk resilience and momentum.
ORKA (Oruka Therapeutics, Inc.): the counter-case, on quality, technicals, analyst expectations — but at materially higher volatility, 64.3% against 38.6%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ONCONC on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
ORKAORKA on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
ONCONC on the Momentum factor, by 10 points.
Lower downside
ONCONC on Risk Resilience, by 19 points.
Analyst upside
ORKAORKA on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ONC, analyst targets favor ORKA. That disagreement is the most useful thing on this page.
| Measure | ONC | ORKA | Note |
|---|---|---|---|
| Implied upside to target | +5.1% | +9.2% | ORKA has more room |
| Target dispersion | +12.6% | +13% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 27 | 13 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
1 of 5 covered evidence groups favor ONC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 80 vs 77 |
| Fundamentals | Even | EPS growth -87.5% vs 4.5%; TTM ROE 6.6% vs -4.2% |
| Valuation | Not covered | Not covered |
| Technicals | ORKA | Price vs 50-day 12.8% vs 17.5%; vs 200-day 27.1% vs 45% |
| Risk Resilience | ONC | Risk Resilience 72 vs 53 |
| Analyst expectations | ORKA | Target upside 5.1% vs 9.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ONC and ORKA and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
- Only 1 of 5 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ONC.
How the comparison changed
45 daily snapshots · Sep 14 – Nov 13ONC lead: Weakening — the AIQ differential moved from 8 to 3 points over 30 sessions.
- Today
- ONC +3
- 80 vs 77
- 7 sessions ago
- ONC +2
- 78 vs 76
- 30 sessions ago
- ONC +8
- 76 vs 68
- 90 sessions ago
- Not covered
The lead changed hands once in this window, most recently on Oct 5 when ONC moved ahead of ORKA.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
6 bullish / 1 bearish, conflicted
Only ONC
- 52-Week High Proximity — bullish, risk_regime, long horizon (1.8%)
- Keltner Channel Breakout — bullish, volatility, short horizon
4 bullish / 1 bearish / 1 neutral, conflicted
Only ORKA
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.37%)
Both carry 5 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, TRIX Bullish Signal, Uptrend Structure Active.
ONC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.14%, AIQ 0 points).
Price and the AIQ Score both moved up over the latest session (price +0.34%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1ORKA closes the Risk Resilience gap — currently 19 points behind, the largest single contributor to ONC's edge.
- 2ORKA's Low Volume Rally Warning resolves — a bearish volume rule currently active against it.
- 3ONC's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
- 4The narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 3-point move would eliminate ONC's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | ONC | ORKA |
|---|---|---|
| Revenue growth (YoY) | 10.8% | 0% |
| EPS growth (YoY) | -87.5% | 4.5% |
| Gross margin | 88.4% | 0% |
| Operating margin | 17.8% | 0% |
| Return on equity (TTM) | 6.6% | -4.2% |
| Debt to equity | 0.2 | 0 |
Performance
ORKA leads 5 of 6 windows| Metric | ONC | ORKA |
|---|---|---|
| 1 week (5 sessions) | 2.4% | 2.4% |
| 1 month (20 sessions) | 12.9% | 46.5% |
| 3 months (63 sessions) | 14.9% | -6.5% |
| 6 months (126 sessions) | 42% | 70.1% |
| Year to date | 37.1% | 247.6% |
| 1 year (252 sessions) | 10.4% | 272.3% |
Technicals
ORKA has the stronger structure| Metric | ONC | ORKA |
|---|---|---|
| RSI (14) | 67.5 | 64.4 |
| ADX (14) | 19.8 | 35.2 |
| Price vs 50-day | 12.8% | 17.5% |
| Price vs 200-day | 27.1% | 45% |
| Volatility (1M, annualized) | 38.6% | 64.3% |
Risk
ONC is the more resilient| Metric | ONC | ORKA |
|---|---|---|
| Beta | 0.68 | 1.4 |
| Sharpe ratio | 0.42 | 2.29 |
| Sortino ratio | 0.62 | 4.3 |
| Max drawdown | -30.9% | -36.4% |
| Current drawdown | -1.8% | -6.8% |
| Annualized volatility | 34.2% | 69.1% |
| Value at risk (95%) | -3% | -5.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ONC or ORKA?
On the Algovestiq AIQ Score, ONC is the stronger of the two as of Nov 15, 2026, scoring 80 against ORKA's 77. The edge comes from risk resilience and momentum. ORKA is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ONC or ORKA the better buy right now?
ONC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 1 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.
Why does the AIQ Score favor ONC over ORKA?
The composite weights Quality, Value, Momentum and Risk Resilience. ONC leads Risk Resilience by 19 points; ONC leads Momentum by 10 points; ORKA leads Quality by 5 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ONC or ORKA?
Analyst price targets imply +5.1% upside for ONC and +9.2% for ORKA, so the Street currently favors ORKA. That points the opposite way to the AIQ Score, which favors ONC. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ONC or ORKA?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ONC or ORKA?
ORKA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ONC or ORKA?
ONC on the Momentum factor, by 10 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ONC or ORKA?
ONC is the more resilient of the two, so the other name carries the higher downside risk. ONC on Risk Resilience, by 19 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ONC more profitable than ORKA?
ONC leads on the comparable margin measures — gross margin 88.4% vs 0%; operating margin 17.8% vs 0%; ttm roe 6.6% vs -4.2%.
Is ONC's lead over ORKA getting stronger or weaker?
ONC lead: Weakening — the AIQ differential moved from 8 to 3 points over 30 sessions. This is measured from 45 daily comparison snapshots between 2026-09-14 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-10-05, when ONC moved ahead of ORKA.
What would change the ONC vs ORKA verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ORKA closes the Risk Resilience gap — currently 19 points behind, the largest single contributor to ONC's edge; ORKA's Low Volume Rally Warning resolves — a bearish volume rule currently active against it; ONC's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 3-point move would eliminate ONC's advantage entirely.
What do the current signals say about ONC and ORKA?
ONC: 6 bullish / 1 bearish, conflicted. ORKA: 4 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ONC is Golden Cross Active (bullish, long horizon). On ORKA it is Golden Cross Active (bullish, long horizon).
Compare ONC and ORKA with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.